文献速递神经介入DSA

水凝胶弹簧圈与裸铂弹簧圈治疗破裂及未破裂颅内动脉瘤:随机对照试验的系统评价与Meta分析更新

Hydrogel Coils versus Bare Platinum Coils for the Treatment of Ruptured and Unruptured Aneurysms: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-07-01

该系统评价与Meta分析纳入5项随机对照试验共2126例患者(水凝胶弹簧圈组1064例,裸铂弹簧圈组1062例),比较水凝胶弹簧圈与裸铂弹簧圈治疗颅内动脉瘤的疗效。水凝胶弹簧圈在平均18个月随访时显著降低主要复发率(RR=0.75,95%CI=0.60-0.94,P=.03),而即刻完全闭塞率、并发症、mRS 0-2及死亡率两组相似。

要点

  • 水凝胶弹簧圈组主要复发率显著低于裸铂弹簧圈组(RR=0.75,95%CI=0.60-0.94,P=.03)。
  • 排除离群值后,水凝胶弹簧圈组末次随访完全闭塞率更高(RR=1.29,95%CI=1.18-1.42,P<.001)。
  • 两组即刻完全闭塞率、并发症、mRS 0-2及死亡率均无显著差异。

核心结论

  • 随机对照试验的Meta分析提示,水凝胶弹簧圈用于颅内动脉瘤血管内治疗时,主要复发率显著低于裸铂弹簧圈,而两组初始闭塞率和安全性相似。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA 2020指南,检索PubMed、Scopus、Embase和Web of Science,纳入5项比较水凝胶弹簧圈与裸铂弹簧圈的随机对照试验,共2126例患者(水凝胶弹簧圈组1064例,裸铂弹簧圈组1062例)。

诊断标准与关键数值

  • 即刻完全闭塞率:水凝胶弹簧圈组与裸铂弹簧圈组相比RR=0.89(95%CI=0.68-1.16,P=.29),无显著差异。
  • 主要复发率(平均18个月随访):水凝胶弹簧圈组与裸铂弹簧圈组相比RR=0.75(95%CI=0.60-0.94,P=.03),水凝胶弹簧圈组显著降低。
  • 末次随访完全闭塞率(排除离群值后):水凝胶弹簧圈组与裸铂弹簧圈组相比RR=1.29(95%CI=1.18-1.42,P<.001),水凝胶弹簧圈组更高。
  • mRS 0-2:水凝胶弹簧圈组与裸铂弹簧圈组相比RR=0.98(95%CI=0.95-1.01,P=.15),无显著差异。
  • 死亡率:水凝胶弹簧圈组与裸铂弹簧圈组相比RR=0.72(95%CI=0.31-1.65,P=.33),无显著差异。

临床应用与阅片要点

  • 作者认为,水凝胶弹簧圈用于颅内动脉瘤血管内治疗时主要复发率显著低于裸铂弹簧圈,两组初始闭塞率和安全性相似。

局限性

  • 仅纳入5项随机对照试验,可能限制研究结果的普遍性。
  • 缺乏长期随访,限制了对治疗持久性的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Whether hydrogel coils (HGCs) can reduce intracranial aneurysm recurrences when compared with bare platinum coils (BPCs) remains a disputed subject. Thus, we sought to perform a systematic review and meta-analysis to evaluate the efficacy of hydrogel coils in the context of intracranial aneurysm treatment.

MATERIALS AND METHODS: Following PRISMA 2020 guidelines, we systematically reviewed PubMed, Scopus, Embase, and Web of Science for randomized controlled trials (RCTs) comparing HGC to BPC. Outcomes of interest were: end of procedure and last follow-up occlusion rates, including complete occlusion and major recurrence, complication rates, morbidity, and mortality. Risk ratios (RRs) and 95% CIs were calculated.

RESULTS: The study selection: 5 RCTs, including 2126 patients (HGC n = 1064, BPC n = 1062), were analyzed. HGC showed comparable rates of immediate complete occlusion (RR = 0.89, 95% CI = 0.68-1.16, P = .29) and packing attenuation (MD = 27.17, 95% CI = -16.59-70.93, P = .12) compared with BPC. At an average 18-month follow-up, HGC significantly reduced major recurrence rates (RR = 0.75, 95% CI = 0.60-0.94, P = .03). Complete occlusion rates at the last follow-up were higher for HGC after outlier exclusion (RR = 1.29, 95% CI = 1.18-1.42, P < .001). All the outcomes related to complications, including hemorrhagic and thromboembolic complications, were similar between both groups (P > .1 for all). Finally, HGC resulted in similar rates of mRS 0-2 and mortality compared with BPC (RR = 0.98, 95% CI = 0.95-1.01, P = .15 and RR = 0.72, 95% CI = 0.31-1.65, P = .33, respectively). Only 5 RCTs were included in this meta-analysis, which may limit the generalizability of our findings. The absence of long-term follow-up also limits the assessment of treatment durability.

CONCLUSIONS: Our meta-analysis of RCTs suggests that the use of HGC in the endovascular treatment of intracranial aneurysms results in significantly lower rates of recurrence compared with BPC, with both coil types showing similar initial occlusion rates and safety profiles.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Cortese J, Ghozy S, Zarrintan A, et al. Hydrogel Coils versus Bare Platinum Coils for the Treatment of Ruptured and Unruptured Aneurysms: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. AJNR Am J Neuroradiol. 2025. PMID: 40592527. doi:10.3174/ajnr.A8697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。